Phase I Study of Cytokine-Gene Modified Autologous Neuroblastoma Cells for Treatment 
of Relapsed/Refractory Neuroblastoma 
Principal Investigator 
Malcolm K. Brenner, MB,PhD,FRCP,MRCPath 
Co-Principal Investigators 
Wayne L. Furman, M.D. 
Victor M.Santana, M.D. 
Laura Bowman, M.D. 
William Meyer, M.D. 
Department of Hematology-Oncology 
Co-Investigators 
William M. Crist, M.D. 
Dario Campana, Ph.D., M.D. 
Edwin C. Douglass MD 
James Ihle, Ph.D. 
James Boyett, Ph.D. 
Julia Hurwitz, Ph.D. 
Bhaskar N. Rao, M.D. 
Jesse J. Jenkins, M.D. 
Barry Fletcher M.D. 
William Kaufman, M.D. 
Robert Moen, M.D., Genetic Therapy, Inc. 
Dan Kuebing, Ph.D., Genetic Therapy, Inc. 
St. Jude Children’s Research Hospital 
332 North Lauderdale, P. O. Box 318 
Memphis, Tennessee 38101-0318 
Telephone: (901) 522-0300 
REVISED IN ACCORDANCE WITH REVIEWS OF HGTS/RAC 
REVISED STATEMENTS ARE ITALICll ^ 
[744] 
Recombinant DNA Research, Volume 15 
